Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Lipid-lowering therapy in patients with renal disease
Ziad A. Massy
, Jennie Z. Ma
, Thomas A. Louis
, Bertram L. Kasiske
Research output
:
Contribution to journal
›
Article
›
peer-review
137
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lipid-lowering therapy in patients with renal disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Kidney Disease
100%
Lipid
100%
Low Density Lipoprotein Cholesterol
60%
Meta Analysis
40%
Kidney Failure
40%
Hemodialysis
40%
Continuous Ambulatory Peritoneal Dialysis
40%
Nephrotic Syndrome
40%
Efficacy
40%
Lipid Blood Level
20%
Lipid Level
20%
Fibric Acid Derivative
20%
Placebo
20%
Kidney Graft
20%
Confidence Interval
20%
Multiple Linear Regression Analysis
20%
Triacylglycerol
20%
Coenzyme A
20%
Accident Prevention
20%
Clinical Trial
20%
Medicine and Dentistry
Lipid
100%
Nephropathy
100%
Low Density Lipoprotein Cholesterol
50%
Meta-Analysis
33%
Nephrotic Syndrome
33%
Renal Failure
33%
Hemodialysis
33%
Continuous Ambulatory Peritoneal Dialysis
33%
Clinical Trial
16%
Kidney Graft
16%
Triacylglycerol
16%
Multiple Linear Regression Analysis
16%
Oxidoreductase
16%
Coenzyme A
16%
Placebo Effect
16%
Treatment Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lipid
100%
Kidney Disease
100%
Low Density Lipoprotein Cholesterol
50%
Kidney Failure
33%
Hemodialysis
33%
Nephrotic Syndrome
33%
Clinical Trial
16%
Placebo
16%
Triacylglycerol
16%
Coenzyme A
16%
Oxidoreductase
16%
Fibric Acid Derivative
16%
Relative Efficacy
16%
Keyphrases
Fibric Acids
20%